Guardant Health, Inc. (GH) financials

Guardant Health, Inc. (GH) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Guardant Health, Inc. reported revenue of $982M, up 32.9% year over year, net income of -$416M, diluted EPS of -$3.32 and free cash flow of -$233M.

Revenue (fiscal 2025)

$982M

Revenue growth (fiscal 2025)

32.9%

Net income (fiscal 2025)

-$416M

Diluted EPS (fiscal 2025)

-$3.32

Free cash flow (fiscal 2025)

-$233M

Guardant Health, Inc. files with the U.S. Securities and Exchange Commission under CIK 0001576280, classified as Services-Medical Laboratories.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.